These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1604050)

  • 1. Effect of repeated administration of chelating agents on distribution, excretion, and renal toxicity of gold sodium thiomalate in rats.
    Takahashi Y; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):253-6. PubMed ID: 1604050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of chelating agents on distribution, excretion, and renal toxicity of gold sodium thiomalate in rats.
    Takahashi Y; Funakoshi T; Shimada H; Kojima S
    Toxicology; 1994 May; 90(1-2):39-51. PubMed ID: 8023341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of chelating agents against renal toxicity of gold sodium thiomalate in rats.
    Kojima S; Takahashi Y; Kiyozumi M; Tagawa Y
    Arch Toxicol; 1991; 65(7):532-6. PubMed ID: 1664200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of chelating agents as antidotes for nephrotoxicity of gold sodium thiomalate in adjuvant-arthritic rats.
    Takahashi Y; Funakoshi T; Shimada H; Kojima S
    Toxicology; 1995 Mar; 97(1-3):151-7. PubMed ID: 7716781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in the renal toxicity of the antiarthritic drug, gold sodium thiomalate.
    Cheriathundam E; Alvares AP
    J Biochem Toxicol; 1996; 11(4):175-81. PubMed ID: 9062847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of gold in urine and bile following administration of gold sodium thiomalate with chelating agents to rats.
    Kojima S; Takahashi Y; Kiyozumi M; Funakoshi T; Shimada H
    Toxicology; 1992 Aug; 74(1):1-8. PubMed ID: 1325079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chelating agents on tissue distribution and excretion of nickel in mice.
    Xie J; Funakoshi T; Shimada H; Kojima S
    Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):245-55. PubMed ID: 7881873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold disposition in the rat: studies of its plasma half-life and its urinary, biliary and fecal elimination pathways.
    Massarella JW; Pearlman RS
    J Pharmacol Exp Ther; 1987 Oct; 243(1):247-57. PubMed ID: 3118007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of repeated parenteral administration of several chelators on the distribution and excretion of cobalt.
    Llobet JM; Domingo JL; Corbella J
    Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):225-33. PubMed ID: 2839877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute nephropathy induced by gold sodium thiomalate: alterations in renal heme metabolism and morphology.
    Eiseman JL; Ribas JL; Knight E; Alvares AP
    Toxicol Appl Pharmacol; 1987 Nov; 91(2):193-203. PubMed ID: 3118510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subacute and chronic toxicity of SK&F 36914, SK&F D-39162 and gold sodium thiomalate in rats.
    Payne BJ; Arena E
    Vet Pathol Suppl; 1978 Aug; 15(5):13-22. PubMed ID: 108849
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative effects of chelating agents on distribution, excretion, and renal toxicity of inorganic mercury in rats.
    Kojima S; Shimada H; Kiyozumi M
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):471-84. PubMed ID: 2781144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of heme metabolism and monooxygeneses in liver and kidney: influence of therapeutically used gold compounds.
    Gondal JA; Eiseman JL; Alvares AP
    J Pharmacol Exp Ther; 1987 May; 241(2):540-6. PubMed ID: 3106619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
    Juresa D; Blanusa M; Kostial K
    Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in urinary enzyme activity and histochemical findings in experimental tubular injury induced by gold sodium thiomalate.
    Ogura T; Takaoka M; Yamauchi T; Oishi T; Mimura Y; Hashimoto M; Asano N; Yamamura M; Otsuka F; Makino H; Ota Z; Takahashi K
    J Med; 1996; 27(1-2):41-55. PubMed ID: 8863177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methimazole protection of rats against chemically induced kidney damage in vivo.
    Sausen PJ; Elfarra AA; Cooley AJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):393-401. PubMed ID: 1731048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):121-31. PubMed ID: 7839359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of thiol containing chelating agents against liver injury induced by hexavalent chromium in mice.
    Ueno S
    Kitasato Arch Exp Med; 1992 Sep; 65(2-3):87-96. PubMed ID: 1339196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of some chelating agents on the biliary excretion of mercury. 1. Excretion kinetics and distribution of mercury in the organism.
    Cikrt M; Tichý M
    J Hyg Epidemiol Microbiol Immunol; 1980; 24(3):346-55. PubMed ID: 7440969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.